Sina Houshmand, MD

Assistant Professor
View full UCSF Profile

Biography

Dr. Houshmand earned his medical degree (MD) at the Shahid Beheshti University of Medical Sciences, Tehran, Iran, followed by a postdoctoral research fellowship at the University of Pennsylvania. After finishing his internship in internal medicine at Albert Einstein College of Medicine/Montefiore Medical Center Wakefield Campus in New York City, Dr. Houshmand completed his diagnostic radiology residency at University of Pittsburgh Medical Center and most recently, his abdominal imaging and ultrasound fellowship at UCSF.

Dr. Houshmand received the Radiology Resident Distinguished Achievement Award during residency for his commitment to scholarship, accomplishment, service, and innovation. His recent research has included novel applications of PET for pediatric disorders, the use of 18F-NaF and 18F-FDG as molecular probes to evaluate atherosclerosis, and the evolving role of molecular imaging with 18F-sodium fluoride PET as a biomarker for calcium metabolism.

Education

06/2021 - Diagnostic Radiology Residency, University of Pittsburgh Medical Center

Honors and Awards

Radiology Resident Distinguished Achievement Award, University of Pittsburgh Medical Center, 2021

Publications

Wang J, Ashraf Ganjouei A, Romero-Hernandez F, Foroutani L, Bahceci D, Deranteriassian A, Casey M, Li PY, Houshmand S, Behr S, Jamshidi N, Majumdar S, Donahue T, Kim GE, Wang ZJ, Thornblade LW, Adam M, Alseidi A. A Computer Vision Algorithm to Predict Superior Mesenteric Artery Margin Status for Patients with Pancreatic Ductal Adenocarcinoma. Ann Surg. 2024 Aug 23.
Vahdati S, Khosravi B, Mahmoudi E, Zhang K, Rouzrokh P, Faghani S, Moassefi M, Tahmasebi A, Andriole KP, Chang P, Farahani K, Flores MG, Folio L, Houshmand S, Giger ML, Gichoya JW, Erickson BJ. A Guideline for Open-Source Tools to Make Medical Imaging Data Ready for Artificial Intelligence Applications: A Society of Imaging Informatics in Medicine (SIIM) Survey. J Imaging Inform Med. 2024 Oct; 37(5):2015-2024.
Houshmand S, Lawhn-Heath C, Behr S. PSMA PET imaging in the diagnosis and management of prostate cancer. Abdom Radiol (NY). 2023 12; 48(12):3610-3623.
Alavi A, Houshmand S, Werner TJ, Zaidi H. Potential Applications of PET-Based Novel Quantitative Techniques in Pediatric Diseases and Disorders. PET Clin. 2020 Jul; 15(3):281-284.
Al-Zaghal A, Aras M, Borja AJ, Moghbel M, Demir Y, Houshmand S, Ciftci E, Werner TJ, Høilund-Carlsen PF, Torigian DA, Han Y, Alavi A. Detection of pulmonary artery atherosclerosis by FDG-PET/CT: a new observation. Am J Nucl Med Mol Imaging. 2020; 10(3):127-134.
Khaw TH, Raynor WY, Borja AJ, Al-Zaghal A, Jonnakuti VS, Cheng N, Houshmand S, Werner TJ, Alavi A. Assessing the effects of body weight on subchondral bone formation with quantitative 18F-sodium fluoride PET. Ann Nucl Med. 2020 Aug; 34(8):559-564.
Boursi B, Werner TJ, Gholami S, Margalit O, Baruch E, Markel G, Eshet Y, Houshmand S, Shacham-Shmueli E, Mitchell TC, Mamtani R, Alavi A, Yang YX. Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanoma. Melanoma Res. 2019 06; 29(3):318-321.
Rice SR, Saboury B, Houshmand S, Salavati A, Kalbasi A, Goodman CR, Werner TJ, Vujaskovic Z, Simone CB, Alavi A. Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy. Nucl Med Commun. 2019 Jun; 40(6):618-625.
McKenney-Drake ML, Moghbel MC, Paydary K, Alloosh M, Houshmand S, Moe S, Salavati A, Sturek JM, Territo PR, Weaver C, Werner TJ, Høilund-Carlsen PF, Sturek M, Alavi A. 18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis. Eur J Nucl Med Mol Imaging. 2018 11; 45(12):2190-2200.
Boursi B, Werner TJ, Gholami S, Houshmand S, Mamtani R, Lewis JD, Wu GD, Alavi A, Yang YX. Functional imaging of the interaction between gut microbiota and the human host: A proof-of-concept clinical study evaluating novel use for 18F-FDG PET-CT. PLoS One. 2018; 13(2):e0192747.
Salavati A, Duan F, Snyder BS, Wei B, Houshmand S, Khiewvan B, Opanowski A, Simone CB, Siegel BA, Machtay M, Alavi A. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial. Eur J Nucl Med Mol Imaging. 2017 Nov; 44(12):1969-1983.
Khiewvan B, Torigian DA, Emamzadehfard S, Paydary K, Salavati A, Houshmand S, Werner TJ, Alavi A. An update on the role of PET/CT and PET/MRI in ovarian cancer. Eur J Nucl Med Mol Imaging. 2017 Jun; 44(6):1079-1091.
Khiewvan B, Torigian DA, Emamzadehfard S, Paydary K, Salavati A, Houshmand S, Shamchi SP, Werner TJ, Aydin A, Roy SG, Alavi A, Kumar R. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer. Hell J Nucl Med. 2016 Sep-Dec; 19(3):254-268.
Segtnan EA, Grupe P, Jarden JO, Gerke O, Ivanidze J, Christlieb SB, Constantinescu C, Pedersen JE, Houshmand S, Hess S, Zarei M, Gjedde A, Alavi A, Høilund-Carlsen PF. Prognostic Implications of Total Hemispheric Glucose Metabolism Ratio in Cerebrocerebellar Diaschisis. J Nucl Med. 2017 05; 58(5):768-773.
Raynor W, Houshmand S, Gholami S, Emamzadehfard S, Rajapakse CS, Blomberg BA, Werner TJ, Høilund-Carlsen PF, Baker JF, Alavi A. Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism. Curr Osteoporos Rep. 2016 08; 14(4):115-25.
Peter J, Houshmand S, Werner TJ, Rubello D, Alavi A. Novel assessment of global metabolism by 18F-FDG-PET for localizing affected lobe in temporal lobe epilepsy. Nucl Med Commun. 2016 Aug; 37(8):882-7.
Simone CB, Houshmand S, Kalbasi A, Salavati A, Alavi A. PET-Based Thoracic Radiation Oncology. PET Clin. 2016 Jul; 11(3):319-32.
Peter J, Houshmand S, Werner TJ, Rubello D, Alavi A. Applications of global quantitative 18F-FDG-PET analysis in temporal lobe epilepsy. Nucl Med Commun. 2016 Mar; 37(3):223-30.
Saboury B, Parsons MA, Moghbel M, Rubello D, Brothers A, Torigian DA, Werner TJ, Houshmand S, Basu S, Lam MG, Alavi A. Quantification of aging effects upon global knee inflammation by 18F-FDG-PET. Nucl Med Commun. 2016 Mar; 37(3):254-8.
Ziai P, Hayeri MR, Salei A, Salavati A, Houshmand S, Alavi A, Teytelboym OM. Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology. Radiographics. 2016 Mar-Apr; 36(2):481-96.
Khiewvan B, Ziai P, Houshmand S, Salavati A, Ziai P, Alavi A. The role of PET/CT as a prognosticator and outcome predictor in lung cancer. Expert Rev Respir Med. 2016; 10(3):317-30.
Mahdavi A, Azar R, Shoar MH, Hooshmand S, Mahdavi A, Kharrazi HH. Functional MRI in clinical practice: Assessment of language and motor for pre-surgical planning. Neuroradiol J. 2015 Oct; 28(5):468-73.
Promteangtrong C, Kolber M, Ramchandra P, Moghbel M, Houshmand S, Schöll M, Bai H, Werner TJ, Alavi A, Buchpiguel C. Multimodality Imaging Approach in Alzheimer disease. Part I: Structural MRI, Functional MRI, Diffusion Tensor Imaging and Magnetization Transfer Imaging. Dement Neuropsychol. 2015 Oct-Dec; 9(4):318-329.
Promteangtrong C, Kolber M, Ramchandra P, Moghbel M, Houshmand S, Schöll M, Werner TJ, Alavi A, Buchpiguel C. Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET. Dement Neuropsychol. 2015 Oct-Dec; 9(4):330-342.
Houshmand S, Salavati A, Segtnan EA, Grupe P, Høilund-Carlsen PF, Alavi A. Dual-time-point Imaging and Delayed-time-point Fluorodeoxyglucose-PET/Computed Tomography Imaging in Various Clinical Settings. PET Clin. 2016 Jan; 11(1):65-84.
McKenney-Drake ML, Territo PR, Salavati A, Houshmand S, Persohn S, Liang Y, Alloosh M, Moe SM, Weaver CM, Alavi A, Sturek M. (18)F-NaF PET Imaging of Early Coronary Artery Calcification. JACC Cardiovasc Imaging. 2016 05; 9(5):627-8.
Houshmand S, Boursi B, Salavati A, Simone CB, Alavi A. Applications of Fluorodeoxyglucose PET/Computed Tomography in the Assessment and Prediction of Radiation Therapy-related Complications. PET Clin. 2015 Oct; 10(4):555-71.
Blomberg BA, Bashyam A, Ramachandran A, Gholami S, Houshmand S, Salavati A, Werner T, Zaidi H, Alavi A. Quantifying [¹⁸F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction. Eur J Nucl Med Mol Imaging. 2015 Aug; 42(9):1414-22.
Gholami S, Salavati A, Houshmand S, Werner TJ, Alavi A. Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification. J Nucl Cardiol. 2015 Jun; 22(3):468-79.
Marin-Oyaga VA, Salavati A, Houshmand S, Pasha AK, Gharavi M, Saboury B, Basu S, Torigian DA, Alavi A. Feasibility and performance of an adaptive contrast-oriented FDG PET/CT quantification technique for global disease assessment of malignant pleural mesothelioma and a brief review of the literature. Hell J Nucl Med. 2015 Jan-Apr; 18(1):11-8.
Salavati A, Borofsky S, Boon-Keng TK, Houshmand S, Khiewvan B, Saboury B, Codreanu I, Torigian DA, Zaidi H, Alavi A. Application of partial volume effect correction and 4D PET in the quantification of FDG avid lung lesions. Mol Imaging Biol. 2015 Feb; 17(1):140-8.
Houshmand S, Salavati A, Hess S, Werner TJ, Alavi A, Zaidi H. An update on novel quantitative techniques in the context of evolving whole-body PET imaging. PET Clin. 2015 Jan; 10(1):45-58.
Houshmand S, Salavati A, Hess S, Ravina M, Alavi A. The role of molecular imaging in diagnosis of deep vein thrombosis. Am J Nucl Med Mol Imaging. 2014; 4(5):406-25.
Mahdavi A, Houshmand S, Oghabian MA, Zarei M, Mahdavi A, Shoar MH, Ghanaati H. Developing optimized fMRI protocol for clinical use: comparison of different language paradigms. J Magn Reson Imaging. 2011 Aug; 34(2):413-9.
Mahdavi A, Saberi H, Hooshmand S, Rezvanizadeh A, Lavasani A, Nilipour R, Zarei M, Oghabian MA. Cortical representation of Persian word production: an fMRI study. Arch Iran Med. 2010 May; 13(3):223-9.